Quotientbd blood bank transfusion reagents

Ended Awarded Last action

Contract number
36C25923N0223
Awardee
Awarding agency
Obligated
$19,671

Award facts

Contract value 100% obligated
$19,671.10 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Contracting staff
Set-aside
No set-aside
Competition
Full and Open Competition Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Chicago, IL 60607, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00003 -$26,744
Funding Only Action P00002 -$4,717
Funding Only Action P00001 -$3,794
Original award $54,925

About this award

This is a federal contract award to Alba Bioscience, Inc., a subsidiary of Quotient Biodiagnostics, Inc., for the supply of blood bank transfusion reagents to the U.S. Department of Veterans Affairs (VA). The contract is a Blanket Purchase Agreement (BPA) under the General Services Administration (GSA) Schedule 65-VII for in vitro diagnostics, reagents, and tests, with a ceiling value of $19,671.10. The contract has an ultimate completion date of May 31, 2024 and is a Firm Fixed Price contract type. This award is part of the VA's larger procurement of specialized blood banking products to support diagnostic testing, blood typing, and transfusion services across its integrated healthcare system. The contract was awarded without a set-aside designation, indicating Alba Bioscience's competitive position in providing these critical medical supplies to federal healthcare agencies.

Quick answers

Who was awarded contract 36C25923N0223?

36C25923N0223 was awarded to Alba Bioscience, Inc. by Veterans Integrated Service Network 19 (Veterans Health Administration) on June 1, 2023.

How much is contract 36C25923N0223 worth?

The government has obligated $19,671 on 36C25923N0223.

Is contract 36C25923N0223 an order under another contract?

Yes. 36C25923N0223 is a BPA call under 36F79721D0259-36C25923A0014, a blanket purchase agreement, on Invitro Diagnostics, Reagents, Test (FSS-65-VII).

Was contract 36C25923N0223 competed?

The extent of competition for 36C25923N0223 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award